发明授权
US08202895B2 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
有权
取代的2-乙酰氨基-5-芳基-1,2,4-三唑酮及其用途
- 专利标题： Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
- 专利标题（中）： 取代的2-乙酰氨基-5-芳基-1,2,4-三唑酮及其用途
-
申请号： US12727044申请日： 2010-03-18
-
公开(公告)号： US08202895B2公开(公告)日： 2012-06-19
- 发明人: Ulf Brüggemeier , Chantal Fürstner , Volker Geiβ , Joerg Keldenich , Armin Kern , Martina Delbeck , Peter Kolkhof , Axel Kretschmer , Elisabeth Pook , Carsten Schmeck , Hubert Trübel
- 申请人： Ulf Brüggemeier , Chantal Fürstner , Volker Geiβ , Joerg Keldenich , Armin Kern , Martina Delbeck , Peter Kolkhof , Axel Kretschmer , Elisabeth Pook , Carsten Schmeck , Hubert Trübel
- 申请人地址： DE Berlin
- 专利权人： Bayer Pharma Aktiengesellschaft
- 当前专利权人： Bayer Pharma Aktiengesellschaft
- 当前专利权人地址： DE Berlin
- 代理商 Karen B. King
- 优先权： DE102009013640 20090318; DE102010001064 20100120
- 主分类号： C07D249/12
- IPC分类号： C07D249/12 ; C07D233/32 ; C07D263/18 ; A61K31/4166 ; A61K31/4196 ; A61K31/421
摘要：
The present application relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.
公开/授权文献
信息查询
